Environmental Impact Acquisition Corp.
ENVI
NASDAQ Capital Market8.82
USD
+0.25
- -
CIK
0001822691
ISIN
US29408N1063
CUSIP
29408N106
Return %
Stock
S&P500
1Y
- -
26.53
3Y
-10.00
76.60
5Y
-10.00
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 535 Madison Avenue New York City NY United States of America 10022
- IPO Date
- Mar 8, 2021
- CIK
- 0001822691
- Website
- canaccordgenuity.com
- Similar Companies
- Business
- GreenLight Biosciences Holdings, a public-benefit corporation, is focused on developing solutions leveraging its proprietary RNA platform. The company researches, designs, and manufactures RNA-based products for applications in both human health and agriculture. In human health, this includes mRNA vaccines and therapeutics, while in agriculture, the company creates RNA solutions to safeguard honeybees and various crops. This entity emerged from the business combination with Environmental Impact Acquisition Corp., completed in February 2022, which transitioned the former special purpose acquisition company into an operational biotechnology firm.
Cerrado Gold Responds to Purported Unfavourable Opinion of Environmental Impact Assessment for the Lagoa Salgada Project, Portugal
Cerrado Gold Announces Tacit Approval of Environmental Impact Assessment for the Lagoa Salgada Project, Portugal
GreenLight Biosciences opens RNA production facility for the next generation of agricultural products
Vaccine developer GreenLight is going public in a $1.5 billion SPAC deal